Canopy Clinical Research picks Clinrol for recruitment

Canopy Clinical Research has selected Clinrol as its preferred patient recruitment technology partner across five locations. The deal makes Canopy one of the first major Australian clinical research site networks to adopt a dedicated recruitment platform separate from its trial management system.

The partnership addresses a growing problem for clinical trial operators: moving large volumes of patient enquiries through screening and enrolment without losing suitable candidates. Site teams often juggle calls, messaging, scheduling and data entry across several systems, while coordinators may handle 100 or more calls a day.

That workload can directly affect trial timelines. According to the companies, more than 30% of patient referrals do not convert to enrolment, not necessarily because patients are unsuitable, but because site staff struggle to manage the volume of follow-up required.

Canopy wanted a centralised system to bring those processes together and provide clearer oversight of the patient journey. Clinrol Connect now serves as the recruitment layer for select studies across the network, while integrating with Canopy's clinical trial management system.

Operational shift

The system was implemented across live studies rather than through a conventional staged deployment. That allowed Canopy's recruitment and operations teams to test and refine workflows in active trial settings.

The new workflow consolidates call handling, automates reminders and rescheduling, and adds structured phone screening with live eligibility checks. The platform also uses artificial intelligence to rank patients by their likelihood of qualifying for a study.

The change was framed as an operational redesign, not a replacement for staff-led recruitment. Human phone contact remains central to Canopy's model, with the software intended to help staff decide which calls to prioritise, how to structure conversations and when to follow up.

That distinction matters in a sector where clinical trial sites are under pressure to recruit faster while maintaining compliance, patient communication and study fit. Traditional clinical trial management systems are typically built around trial operations, while recruitment requires high-volume contact management and front-end screening.

Recruitment pressure

Patient recruitment is widely seen as one of the biggest causes of delay in clinical trials. Australia's geography and population distribution add another layer of difficulty, especially for multi-site studies trying to identify and enrol participants in narrow eligibility groups.

Canopy operates across multiple therapeutic areas and study phases, and its growth has increased the need for a uniform system across sites. The move reflects a broader trend in health technology towards more specialised software tools operating alongside established trial management platforms.

For site networks, the challenge is not only finding enough potential participants, but also handling incoming demand in a way that turns interest into enrolment. A patient may respond to an advertisement or referral, but each extra step, missed call or delayed response increases the risk of dropping out before screening is complete.

Against that backdrop, software focused on patient engagement and pre-screening has drawn more attention from research operators looking to improve throughput without expanding headcount at the same rate. In Canopy's case, the priority was to reduce duplicated effort and make the recruitment funnel more visible.

"Patient recruitment remains a major barrier to clinical trial completion globally, particularly in Australia, where population size and geography add complexity," said Kris Barooshian, Chief Executive Officer, Canopy Clinical Research.

"As a rapidly growing research network, we identified the need for a uniform platform that could bring together patient engagement and recruitment operations into one place," said Barooshian.

Canopy has used a range of systems in the past to address operational bottlenecks at site level. This time, the focus was on linking outreach, pre-screening, communication and workflow management into a single process rather than relying on separate tools for each step.

"We've used a lot of systems over the years to address key operational and recruitment barriers facing sites. We have been extremely impressed by Clinrol Connect and the level of visibility it has unlocked for our team. We are looking forward to the full rollout over the coming months and to seeing how new technology can help our teams unlock new possibilities," said Barooshian.

Sector signal

The agreement also points to a maturing local market for clinical trial software, with an Australian site network choosing an Australian recruitment platform to handle a critical part of the trial process. While sponsors and contract research organisations have long invested in systems for data capture and trial oversight, recruitment at site level has often remained fragmented.

Clinrol executives said the work with Canopy was built around existing site practices rather than imposing a fixed process from the outset. The software was adjusted alongside Canopy's teams to reflect how recruitment happens on the ground.

"We worked side by side with the Canopy team, mapping how recruitment actually happens on the ground and rebuilding it into a streamlined workflow," said Arjun Bhat, Co-Founder and Chief Executive Officer, Clinrol.

"The goal was to remove friction for teams. When that happens, teams move faster, data improves and the patient experience is elevated, with patients more likely to make it through to enrolment," said Bhat.